Relevant bibliographies by topics / Adenosine receptor antagonists

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Adenosine receptor antagonists'

Author: Grafiati
Published: 4 June 2021
Last updated: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Adenosine receptor antagonists.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Adenosine receptor antagonists"

1

Shang, Liangcheng, Yaobiao Huang, Xin Xie, Sudan Ye, and Chun Chen. "Effect of Adenosine Receptor Antagonists on Adenosine-Pretreated PC12 Cells Exposed to Paraquat." Dose-Response 20, no. 2 (April 2022): 155932582210934. http://dx.doi.org/10.1177/15593258221093411.

Full text
Abstract:
Previous studies evaluated the adenosine receptor antagonists alone to determine their effects on oxidative stress, but little is known about adenosine’s protective efficacy when oxidative injury occurs in vivo. Adenosine is a crucial signaling molecule recognized by four distinct G-protein-coupled receptors (GPCRs) (i.e., A1R, A2AR, A2BR, and A3R) and protects cells against pathological conditions. The present study was performed to evaluate the role of antagonist modulation in the setting of paraquat toxicity with adenosine pretreatment. First, PC12 cells were exposed to paraquat (850 μM) an
APA, Harvard, Vancouver, ISO, and other styles
2

Shi, Yanrong, Xiaoguang Liu, Debebe Gebremedhin, John R. Falck, David R. Harder, and Raymond C. Koehler. "Interaction of Mechanisms Involving Epoxyeicosatrienoic Acids, Adenosine Receptors, and Metabotropic Glutamate Receptors in Neurovascular Coupling in Rat Whisker Barrel Cortex." Journal of Cerebral Blood Flow & Metabolism 28, no. 1 (May 23, 2007): 111–25. http://dx.doi.org/10.1038/sj.jcbfm.9600511.

Full text
Abstract:
Adenosine, astrocyte metabotropic glutamate receptors (mGluRs), and epoxyeicosatrienoic acids (EETs) have been implicated in neurovascular coupling. Although A2A and A2B receptors mediate cerebral vasodilation to adenosine, the role of each receptor in the cerebral blood flow (CBF) response to neural activation remains to be fully elucidated. In addition, adenosine can amplify astrocyte calcium, which may increase arachidonic acid metabolites such as EETs. The interaction of these pathways was investigated by determining if combined treatment with antagonists exerted an additive inhibitory eff
APA, Harvard, Vancouver, ISO, and other styles
3

Bozarov, Andrey, Yu-Zhong Wang, Jun Ge Yu, Jacqueline Wunderlich, Hamdy H. Hassanain, Mazin Alhaj, Helen J. Cooke, Iveta Grants, Tianhua Ren, and Fievos L. Christofi. "Activation of adenosine low-affinity A3 receptors inhibits the enteric short interplexus neural circuit triggered by histamine." American Journal of Physiology-Gastrointestinal and Liver Physiology 297, no. 6 (December 2009): G1147—G1162. http://dx.doi.org/10.1152/ajpgi.00295.2009.

Full text
Abstract:
We tested the novel hypothesis that endogenous adenosine (eADO) activates low-affinity A3 receptors in a model of neurogenic diarrhea in the guinea pig colon. Dimaprit activation of H2 receptors was used to trigger a cyclic coordinated response of contraction and Cl− secretion. Contraction-relaxation was monitored by sonomicrometry (via intracrystal distance) simultaneously with short-circuit current ( Isc, Cl− secretion). The short interplexus reflex coordinated response was attenuated or abolished by antagonists at H2 (cimetidine), 5-hydroxytryptamine 4 receptor (RS39604), neurokinin-1 recep
APA, Harvard, Vancouver, ISO, and other styles
4

Muller, C. "A3 Adenosine Receptor Antagonists." Mini-Reviews in Medicinal Chemistry 1, no. 4 (November 1, 2001): 417–27. http://dx.doi.org/10.2174/1389557510101040417.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Müller, Christa E. "A1-Adenosine receptor antagonists." Expert Opinion on Therapeutic Patents 7, no. 5 (May 1997): 419–40. http://dx.doi.org/10.1517/13543776.7.5.419.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pérez-Pinzón, Miguel A., Peter L. Lutz, Thomas J. Sick, and Myron Rosenthal. "Adenosine, a “Retaliatory” Metabolite, Promotes Anoxia Tolerance in Turtle Brain." Journal of Cerebral Blood Flow & Metabolism 13, no. 4 (July 1993): 728–32. http://dx.doi.org/10.1038/jcbfm.1993.93.

Full text
Abstract:
Contrary to what is found in most vertebrates, the brains of certain turtle species maintain ATP levels and ion homeostasis and survive prolonged anoxia. The hypothesis tested here is that the release of adenosine and its binding to A1 receptors are essential for this anoxic tolerance. Studies were conducted in the isolated turtle cerebellum, which did release adenosine to the extracellular space during anoxia. When adenosine receptor antagonists [theophylline, 8-cyclopentyltheophylline (CPT), or 8-cyclopentyl-1,3-dipropylxanthine (DPCPX)] were added to the superfusate under control conditions
APA, Harvard, Vancouver, ISO, and other styles
7

Temirak, Ahmed, Jonathan G. Schlegel, Jan H. Voss, Victoria J. Vaaßen, Christin Vielmuth, Tobias Claff, and Christa E. Müller. "Irreversible Antagonists for the Adenosine A2B Receptor." Molecules 27, no. 12 (June 13, 2022): 3792. http://dx.doi.org/10.3390/molecules27123792.

Full text
Abstract:
Blockade of the adenosine A2B receptor (A2BAR) represents a potential novel strategy for the immunotherapy of cancer. In the present study, we designed, synthesized, and characterized irreversible A2BAR antagonists based on an 8-p-sulfophenylxanthine scaffold. Irreversible binding was confirmed in radioligand binding and bioluminescence resonance energy transfer(BRET)-based Gα15 protein activation assays by performing ligand wash-out and kinetic experiments. p-(1-Propylxanthin-8-yl)benzene sulfonyl fluoride (6a, PSB-21500) was the most potent and selective irreversible A2BAR antagonist of the
APA, Harvard, Vancouver, ISO, and other styles
8

Fan, Ming, Weixi Qin, and S. Jamal Mustafa. "Characterization of adenosine receptor(s) involved in adenosine-induced bronchoconstriction in an allergic mouse model." American Journal of Physiology-Lung Cellular and Molecular Physiology 284, no. 6 (June 1, 2003): L1012—L1019. http://dx.doi.org/10.1152/ajplung.00353.2002.

Full text
Abstract:
We recently reported that adenosine caused bronchoconstriction and enhanced airway inflammation in an allergic mouse model. In this study, we further report the characterization of the subtype of adenosine receptor(s) involved in bronchoconstriction. 5′-( N-ethylcarboxamido)adenosine (NECA), a nonselective adenosine agonist, elicited bronchoconstriction in a dose-dependent manner. Little effects of N 6-cyclopentyladenosine (A1-selective agonist) and 2- p-(2-carboxyethyl)phenethylamino-5′- N-ethylcarboxamidoadenosine (A2A-selective agonist) compared with NECA were observed in this model. 2-Chlo
APA, Harvard, Vancouver, ISO, and other styles
9

Baraldi, P. G., B. Cacciar, G. Spalluto, A. Borioni, M. Viziano, S. Dionisotti, and E. Ongini. "Current Developments of A2a Adenosine Receptor Antagonists." Current Medicinal Chemistry 2, no. 3 (October 1995): 707–22. http://dx.doi.org/10.2174/092986730203220223144628.

Full text
Abstract:
<P>Adenosine regulates a wide range of physiological functions through specific cell membrane receptors. On the basis of pharmacological studies and molecular cloning, four distinct adenosine receptors have been identified and classified as A1, A2a. A2b and A3. These adenosine receptors are members of the G-protein-coupled receptor family. <P> An intense medicinal chemistry effort made over the last 20 years has led to a variety of selective adenosine receptor agonists and antagonists. While all the agonists thus far identified are related to the adenosine structure, the antagonist
APA, Harvard, Vancouver, ISO, and other styles
10

Tay, Apple Hui Min, Rubén Prieto-Díaz, Shiyong Neo, Le Tong, Xinsong Chen, Valentina Carannante, Björn Önfelt, et al. "A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models." Journal for ImmunoTherapy of Cancer 10, no. 5 (May 2022): e004592. http://dx.doi.org/10.1136/jitc-2022-004592.

Full text
Abstract:
BackgroundAdenosine is a metabolite that suppresses antitumor immune response of T and NK cells via extracellular binding to the two subtypes of adenosine-2 receptors, A2ARs. While blockade of the A2AARs subtype effectively rescues lymphocyte activity, with four A2AAR antagonists currently in anticancer clinical trials, less is known for the therapeutic potential of the other A2BAR blockade within cancer immunotherapy. Recent studies suggest the formation of A2AAR/A2BAR dimers in tissues that coexpress the two receptor subtypes, where the A2BAR plays a dominant role, suggesting it as a promisi
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Adenosine receptor antagonists"

1

Beauglehole, Anthony Robert, and anthony@adenrx com. "N3-substituted xanthines as irreversible adenosine receptor antagonists." Deakin University. School of Biological and Chemical Sciences, 2000. http://tux.lib.deakin.edu.au./adt-VDU/public/adt-VDU20080612.084330.

Full text
Abstract:
8-Cyclopentyl-3-(3-(4-fluorosulfonylbenzoyl)oxy)propyl-propylxanthine (44, FSCPX) has been reported to exhibit potent and selective irreversible antagonism of the A1 adenosine receptor when using in vitro biological preparations. However, FSCPX (44) suffers from cleavage of the ester linkage separating the reactive 4-(fluorosulfonyl)phenyl moiety from the xanthine pharmacophore when used in in vivo biological preparations or preparations containing significant enzyme activity, presumably by esterases. Cleavage
APA, Harvard, Vancouver, ISO, and other styles
2

BARALDI, Stefania. "Design and Synthesis of New A2B Adenosine Receptor Antagonists." Doctoral thesis, Università degli studi di Ferrara, 2009. http://hdl.handle.net/11392/2388704.

Full text
Abstract:
Starting from chemical structure of N-benzo-[1,3]dioxol-5-yl-2-[5-(2,6dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol3-yloxy]-acetamide, MRE2029F20* various structural modifications were realized to afford a new series of A2B antagonists. The bioisosteric replacement of the anilide moiety with benzimidazole or quinazoline rings, the effect of the substitution of pyrazole with isoxazole moiety were investigated. Amide bond has been also replaced with the 5phenyl-1,2,4-oxadiazole nucleus on the basis of other adenosine pharmacophores reported previously. In this con
APA, Harvard, Vancouver, ISO, and other styles
3

Robinson, Sarel Johannes. "Syntheses of chalcones and 2-aminopyrimidines and their evaluation as monoamine oxidase inhibitors and as adenosine receptor antagonists / Sarel Johannes Robinson." Thesis, North-West University, 2013. http://hdl.handle.net/10394/9534.

Full text
Abstract:
Background and rationale - Parkinson’s disease is a neurodegenerative disorder characterised by reduced levels of dopamine in the brain. The cause of Parkinson's disease is still unknown; however several theories pertaining to the etiology exist. Current treatment mainly aims at dopamine replacement, with agents such as levodopa and dopamine agonists that provide patients with symptomatic relief. This relief is unfortunately only temporary as the progression of the disease is not halted. Furthermore, these therapies are associated with a range of side effects and novel approaches to the treat
APA, Harvard, Vancouver, ISO, and other styles
4

McKeveney, Declan, and n/a. "The Solid-Phase Combinatorial Synthesis of 2,6,9- Trisubstituted Purines as Potential Adenosine A3 Receptor Antagonists." Griffith University. School of Science, 2005. http://www4.gu.edu.au:8080/adt-root/public/adt-QGU20050830.120105.

Full text
Abstract:
Purines as a class of compounds have been implicated in many biological systems, including as adenosine receptor antagonists. A method of synthesising 2,6,9-trisubstituted purines would be useful to produce small libraries of compounds for probing adenosine receptor selectivity. A library of trisubstituted purines has been achieved using a solid-phase methodology. The electronic properties of the substrate were found to result in difficulties with the loading of substrate onto the resin. Theoretical calculations provided the basis for mono-substitution in order to activate the substrate. This
APA, Harvard, Vancouver, ISO, and other styles
5

McKeveney, Declan. "The Solid-Phase Combinatorial Synthesis of 2,6,9- Trisubstituted Purines as Potential Adenosine A3 Receptor Antagonists." Thesis, Griffith University, 2005. http://hdl.handle.net/10072/367926.

Full text
Abstract:
Purines as a class of compounds have been implicated in many biological systems, including as adenosine receptor antagonists. A method of synthesising 2,6,9-trisubstituted purines would be useful to produce small libraries of compounds for probing adenosine receptor selectivity. A library of trisubstituted purines has been achieved using a solid-phase methodology. The electronic properties of the substrate were found to result in difficulties with the loading of substrate onto the resin. Theoretical calculations provided the basis for mono-substitution in order to activate the substrate. This
APA, Harvard, Vancouver, ISO, and other styles
6

Morizzo, Erika. "G Protein-Coupled Receptors as Potential Drug Target: From Receptor Topology to Rational Drug Design, an in-silico Approach." Doctoral thesis, Università degli studi di Padova, 2009. http://hdl.handle.net/11577/3426081.

Full text
Abstract:
G protein-coupled receptors (GPCRs) constitute a very large family of heptahelical, integral membrane proteins that mediate a wide variety of physiological processes, ranging from the transmission of the light and odorant signals to the mediation of neurotransmission and hormonal actions. GPCRs are dysfunctional or deregulated in several human diseases and are estimated to be the target of more than 40% of drugs used in clinical medicine today. The crystal structures of rhodopsin and the recent published crystal structures of beta-adrenergic receptors and human A2A Adrenergic Receptor pr
APA, Harvard, Vancouver, ISO, and other styles
7

Affini, Anna [Verfasser]. "Histamine H3 receptor antagonists in combination with monoamine oxidase B and adenosine A1/A2A receptor ligands as multi-target approach for the treatment of Parkinson´s disease / Anna Affini." Düsseldorf : Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf, 2019. http://d-nb.info/1190350807/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Harmse, Rozanne. "Syntheses of 8-(phenoxymethyl)caffeine analogues and their evaluation as inhibitors of monoamine oxidase and as antagonists of the adenosine A2A receptor / Rozanne Harmse." Thesis, North-West University, 2013. http://hdl.handle.net/10394/9663.

Full text
Abstract:
Background and rationale: Parkinson’s disease (PD) is a progressive, degenerative disorder of the central nervous system and is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. The loss of functional dopamine in the striatum is thought to be responsible for the typical symptoms of PD. Cardinal features of PD include bradykinesia, muscular rigidity, resting tremor and impairment of postural balance. This study focuses on the inhibition of monoamine oxidase B (MAO-B) and antagonism of A2A receptors as therapeutic strategies for PD. Monoamine oxidase (MAO)
APA, Harvard, Vancouver, ISO, and other styles
9

Pretorius, Judey. "The synthesis and evaluation of caffeine analogues as inhibitors of monoamine oxidase B and antagonists of the adenosine A₂A receptor / by Judey Pretorius." Thesis, North-West University, 2008. http://hdl.handle.net/10394/4127.

Full text
Abstract:
The adenosine A2A receptor has emerged as an attractive target for the treatment of Parkinson's disease (PD). Evidence suggests that antagonists of the A2A receptor (A2A antagonists) partially alleviate the symptoms of PD, prevent the development of motor complications and may also slow the underlying neurodegenerative process. It was recently reported that several members of the (E)-8-styrylcaffeine class of A2A antagonists also are potent inhibitors of monoamine oxidase B (MAO-B).<br>Thesis (Ph.D. (Pharmaceutical Chemistry))--North-West University, Potchefstroom Campus, 2009.
APA, Harvard, Vancouver, ISO, and other styles
10

Gull, Mazhar [Verfasser], and André [Akademischer Betreuer] Brändli. "In vivo pharmacological profiling in Xenopus embryos defines a subset of A1 adenosine receptor-selective antagonists with potent anti-angiogenic activities / Mazhar Gull ; Betreuer: André Brändli." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2017. http://d-nb.info/1137226765/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Adenosine receptor antagonists"

1

Hiroshi, Kase, Richardson Peter J, and Jenner P. G, eds. Adenosine receptors and Parkinson's disease. San Diego, Calif: Academic, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hiroshi, Kase, Richardson Peter J, and Jenner Peter 1946-, eds. Adenosine receptors and Parkinson's disease. San Diego, CA: Academic Press, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

service), SpringerLink (Online, ed. Adenosine receptors in health and disease. Dordrecht: Springer, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

1953-, Jacobson Kenneth Alan, and Jarvis Michael F, eds. Purinergic approaches in experimental therapeutics. New York: Wiley-Liss, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chen, Jiang-Fan, and Akihisa Mori. Adenosine A2A Receptor Antagonists. Elsevier Science & Technology Books, 2023.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jenner, Peter, Hiroshi Kase, and Peter J. Richardson. Adenosine Receptors and Parkinson's Disease. Elsevier Science & Technology Books, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wilson, Constance N., and S. Jamal Mustafa. Adenosine Receptors in Health and Disease. Springer, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

(Editor), Hiroshi Kase, Peter J. Richardson (Editor), and Peter Jenner (Editor), eds. Adenosine Receptors and Parkinson's Disease (Pure and Applied Mathematics (Academic Press), 60.). Academic Press, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Beninger, Richard J. Dopamine receptor subtypes and incentive learning. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780198824091.003.0007.

Full text
Abstract:
Dopamine receptor subtypes and incentive learning explains that dopamine receptors are G protein-coupled and form two families: D1-like receptors, including D1 and D5, stimulate adenylyl cyclase and cyclic adenosine monophosphate (cAMP); D2-like receptors, including D2, D3, and D4, inhibit cAMP. Antipsychotic medications are dopamine receptor antagonists and their clinical potency is strongly correlated with blockade of D2 receptors, implicating overactivity of D2 receptors in psychosis in schizophrenia. D1- and D2-like receptors appear to be involved in unconditioned locomotor activity and in
APA, Harvard, Vancouver, ISO, and other styles
10

Erlinge, David, and Göran Olivecrona. Diagnosis and management of ST-elevation of myocardial infarction. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0147.

Full text
Abstract:
ST-elevation myocardial infarction (STEMI) is generally caused by a ruptured plaque that triggers local thrombus formation, which occludes the coronary artery. STEMI should be diagnosed rapidly, based on the combination of ST-segment elevation and symptoms of acute myocardial infarction. The main treatment objective is myocardial tissue reperfusion as quickly as possible. The preferred method of reperfusion is primary percutaneous coronary interventionif transport time is below 2 hours, and thrombolysis if longer STEMI patients with acute onset cardiogenic shock should be evaluated by echocard
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Adenosine receptor antagonists"

1

Shook, Brian C. "Adenosine A2A Receptor Antagonists." In Topics in Medicinal Chemistry, 1–42. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/7355_2014_67.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gao, Zhan-Guo, Dilip K. Tosh, Shanu Jain, Jinha Yu, Rama R. Suresh, and Kenneth A. Jacobson. "A1 Adenosine Receptor Agonists, Antagonists, and Allosteric Modulators." In The Adenosine Receptors, 59–89. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-90808-3_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Müller, Christa E., and Kenneth A. Jacobson. "Xanthines as Adenosine Receptor Antagonists." In Methylxanthines, 151–99. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-13443-2_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pinna, Annalisa, Nicola Simola, Lucia Frau, and Micaela Morelli. "Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease." In Adenosine, 361–84. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-3903-5_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Müller, Christa E. "Adenosine A2A Receptor Antagonists in Drug Development." In Current Topics in Neurotoxicity, 39–56. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-20273-0_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ongini, Ennio, Cristina Zocchi, Anna Conti, Monica Viziano, Angela Monopoli, and Silvio Dionisotti. "Biologic Activity of Adenosine A2a Receptor Antagonists." In Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology, 241–48. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-2011-5_28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kiesman, William F., Elfatih Elzein, and Jeff Zablocki. "A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers." In Adenosine Receptors in Health and Disease, 25–58. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-89615-9_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Jacobson, Kenneth A., Athena M. Klutz, Dilip K. Tosh, Andrei A. Ivanov, Delia Preti, and Pier Giovanni Baraldi. "Medicinal Chemistry of the A3 Adenosine Receptor: Agonists, Antagonists, and Receptor Engineering." In Adenosine Receptors in Health and Disease, 123–59. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-89615-9_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Baraldi, Pier Giovanni, Romeo Romagnoli, Giulia Saponaro, Stefania Baraldi, Mojgan Aghazadeh Tabrizi, and Delia Preti. "A3 Adenosine Receptor Antagonists: History and Future Perspectives." In A3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics, 121–47. Dordrecht: Springer Netherlands, 2009. http://dx.doi.org/10.1007/978-90-481-3144-0_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Costa, Giulia, and Micaela Morelli. "Adenosine A2A Receptor Antagonists in L-DOPA-Induced Motor Fluctuations." In Current Topics in Neurotoxicity, 163–82. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-20273-0_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Adenosine receptor antagonists"

1

Calzetta, Luigi, Maria G. Matera, Clive Page, Mario Cazzola, and Domenico Spina. "Effects Of Adenosine Receptor Agonist And Antagonists On Human Isolated Bronchi." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a2129.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lee, Kyungik, Seungah Jun, EunYoung Byun, Hosun Lee, Yongtaek Lee, MiJin Moon, Yu-Yon Kim, et al. "Abstract 4140: Discovery and characterization of novel highly potent A2A adenosine receptor antagonists for cancerimmunotherapy." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-4140.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lee, Kyungik, Seungah Jun, EunYoung Byun, Hosun Lee, Yongtaek Lee, MiJin Moon, Yu-Yon Kim, et al. "Abstract 4140: Discovery and characterization of novel highly potent A2A adenosine receptor antagonists for cancerimmunotherapy." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-4140.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Corsello, Steven M., Ryan D. Spangler, Ranad Humeidi, Caitlin N. Harrington, Rohith T. Nagari, Ritu Singh, Vickie Wang, et al. "Abstract 3400: Adenosine receptor antagonists exhibit potent and selective off-target killing of FOXA1-high cancers." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-3400.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Van Calenbergh, Serge, Andreas Link, Shelly Fujikawa, Veerle Vanheusden, Denis De Keukeleire, Adriaan P. Ijzerman та Piet Herdewijn. "5'-Deoxy congeners of 9-(3-amido-3-deoxy-β-D-xylofuranosyl)-N6-cyclopentyladenine: New adenosine A1 receptor antagonists". У XIth Symposium on Chemistry of Nucleic Acid Components. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 1999. http://dx.doi.org/10.1135/css199902273.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Borges, Fernanda, Maykel Cruz-Monteagudo, Aliuska Morales-Helguera, Yunierkis Pérez-Castillo, M. Natália D. S. Cordeiro, Eduardo Tejera, Cesar Paz-y-Miño, et al. "Virtual screening tailored ensembles of QSAR models for the discovery of dual A2A Adenosine Receptor Antagonists / Monoamine Oxidase B Inhibitors." In MOL2NET, International Conference on Multidisciplinary Sciences. Basel, Switzerland: MDPI, 2015. http://dx.doi.org/10.3390/mol2net-1-b033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

TEIXEIRA, GUILHERME PEGAS, and ROBSON XAVIER FARIA. "INIBIÇÃO DO RECEPTOR PURINÉRGICO P2X7 COMO UMA NOVA ESTRATÉGIA CONTRA DIABETES TIPO 2." In I Congresso Brasileiro de Doenças Crônicas On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/cronics/7456.

Full text
Abstract:
Introdução: A sinalização purinérgica é um sistema de receptores de membrana ativados por purinas, envolvidos em diversos processos fisiológicos e patológicos do organismo. O receptor purinérgico P2X7 é o mais marcante neste sistema. Trata-se de um receptor ionotrópico ativado por adenosina trifosfato (ATP) extracelular com ampla participação na resposta imunológica e na liberação das citocinas pró-inflamatórias IL-1 e IL-18. A superprodução destes mediadores induz resistência à insulina no tecido adiposo e muscular esquelético através da diminuição do transportador de glicose dependente de i
APA, Harvard, Vancouver, ISO, and other styles
8

Wachtfogel, Yanina T., Yizhar Floman, Meir Liebergall, Robert W. Colman, and Amiram Eldor. "PLATELET ALPHA2-ADRENERGIC RECEPTOR ABNORMALITIES IN PATIENTS WITH IDIOPATHK: SCOLIOSIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644567.

Full text
Abstract:
Idiopathic scoliosis is a genetic multisystem disease involving skeletal, biochemical, central nervous svstem, muscle and blood platelet abnormalities. Platelets of patients with idiopathic scoliosis have been shown to have decreased adenosine diphosphate and epinephrine-induced aggregation. Similarities between the contractile protein system of platelets and muscle have made the platelet a popular model for certain aspects of muscle physiology. This study confirmed that 64% of the patient platelets tested exhibited a significantly decreased sensitivity to aggregation bv epinephrine. In seven
APA, Harvard, Vancouver, ISO, and other styles
9

DiRenzo, Daniel, Dana Piovesan, Joanne Tan, Dillon H. Miles, Manmohan R. Leleti, Timothy Park, Ferdie Soriano, et al. "Abstract A162: AB928, a dual antagonist of the A2aR and A2bR adenosine receptors, relieves adenosine-mediated immune suppression." In Abstracts: Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 30 - October 3, 2018; New York, NY. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr18-a162.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Houthuys, Erica, Margreet Brouwer, Florence Nyawouame, Romain Pirson, Reece Marillier, Theo Deregnaucourt, Joao Marchante, et al. "Abstract 1683: A novel adenosine A2A receptor antagonist optimized for high potency in adenosine-rich tumor microenvironment boosts antitumor immunity." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-1683.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Adenosine receptor antagonists' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography